Tag: endpoint

May 13, 2018

5 Top Weekly NASDAQ Biotech Stocks: Helius Up 43.19 Percent

Helius Medical Technologies, vTv Therapeutics, Second Sight Medical Products, Depomed and Senomyx were last week's top gainers on the NASDAQ.
May 9, 2018

Reata Pharmaceuticals Announces First Quarter 2018 Financial Results and an Update on Development Programs

Reata Pharmaceuticals (Nasdaq:RETA), a clinical-stage biopharmaceutical company, today provided an update on the Company’s product development programs and announced financial...
May 9, 2018

Versartis Reports First Quarter 2018 Financial Results

Versartis (Nasdaq:VSAR), an endocrine-focused biopharmaceutical company, today announced financial results for the first quarter ended March 31, 2018. As quoted in...
May 4, 2018

Finjan Files Patent Infringement Complaint Against Check Point USA and Check Point Israel

Finjan Holdings Inc (NASDAQ:FNJN), a global leader in cybersecurity announced that it has filed a patent infringement lawsuit against Check...
April 30, 2018

8 Glioblastoma Treatment Stocks

With an average survival rate of 16 months, glioblastoma is the most common and deadly type of brain cancer, accounting...
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 26, 2018

Axsome Therapeutics Announces Interim Analysis of STRIDE-1 Trial

Shares of Axsome increased nearly 20 percent after the announcement, but evened out to an overall 13.21-percent increase to $3.